Cizzle Biotechnology Holdings (CIZ)

Sector:

Pharma and Biotech

2.80p
   
  • Change Today:
      0.30p
  • 52 Week High: 3.30p
  • 52 Week Low: 1.29p
  • Currency: UK Pounds
  • Shares Issued: 396.39m
  • Volume: 11,363,005
  • Market Cap: £11.10m
  • Beta: 0.02

CIZ Overview

Cizzle Biotechnology is a spin-out from the University of York and is a biotechnology business focused on the early detection of Lung cancer via the development of an immunoassay test for the CIZ1B biomaker. Cizzle Biotechnology was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 65.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CIZ Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (0.01) (2.80)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (3.96) (2.40)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (0.96) (0.30)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.76) (0.50)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (2.19) (0.60)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CIZ Company Announcements

Progress on Launch of Biomarker Test in USA 23-Feb-2026 07:00 RNS
Patent Granted in Canada 04-Feb-2026 07:00 RNS
£250,000 Convertible Loan Note Issue 05-Nov-2025 07:01 RNS

CIZ ShareCast News

No recent information was found.

Latest CIZ Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CIZ Market Data

Currency UK Pounds
Share Price 2.80p
Change Today 0.30p
% Change 12.00 %
52 Week High 3.30p
52 Week Low 1.29p
Volume 11,363,005
Shares Issued 396.39m
Market Cap £11.10m
Beta 0.02

CIZ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.65% below the market average40.65% below the market average40.65% below the market average40.65% below the market average40.65% below the market average
60.98% below the sector average60.98% below the sector average60.98% below the sector average60.98% below the sector average60.98% below the sector average
Price Trend
57.21% below the market average57.21% below the market average57.21% below the market average57.21% below the market average57.21% below the market average
4.55% below the sector average4.55% below the sector average4.55% below the sector average4.55% below the sector average4.55% below the sector average
Income Not Available
Growth Not Available

CIZ Dividends

No dividends found

Trades for 24-Mar-2026

Time Volume / Share Price
16:42 250,000 @ 2.90p
16:19 300,000 @ 2.68p
16:04 351,770 @ 2.67p
16:29 1,948 @ 2.84p
16:28 26,059 @ 2.83p

CIZ Key Personnel

Finance Director Nigel Ronald Lee

Top of Page